UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's disease, delaying BLA plans.
Chevron (NYSE: CVX) exceeded Q3 expectations, thanks to higher production and integrated assets. Analysts reaffirm Buy rating.
Bank of America upgraded Westlake Corp to Buy from Neutral, citing an attractive entry point after third-quarter results.
Lucid stock is trading lower Monday afternoon as shares pull back from momentum following significant strategic announcements last week.
KBR JV to acquire SWAT, creating a top specialty welding & turnaround provider in NA. Deal terms undisclosed. KBR reports Q3 earnings.
AI infrastructure providers are partnering with tech giants and cloud leaders as AI projects secure the power and hardware they need.